These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7917512)

  • 1. IgM antibodies directed to HIV: the neglected issue?
    Van de Perre P; Desgranges C; Burny A
    AIDS Res Hum Retroviruses; 1994 May; 10(5):517-20. PubMed ID: 7917512
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.
    Montefiori DC
    Springer Semin Immunopathol; 1997; 18(3):371-90. PubMed ID: 9089955
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
    Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
    Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity to HIV-1: neutralization and beyond.
    Huber M; Trkola A
    J Intern Med; 2007 Jul; 262(1):5-25. PubMed ID: 17598812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgM antibody therapy for HIV-1 infection.
    Okada N; Okada H
    Microbiol Immunol; 1999; 43(8):729-36. PubMed ID: 10524789
    [No Abstract]   [Full Text] [Related]  

  • 6. Research. 'Superinfected' have more potent antibody response to HIV.
    AIDS Policy Law; 2012 May; 27(6):3. PubMed ID: 22655314
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot.
    Schüpbach J; Wunderli W; Kind C; Kernen R; Baumgartner A; Tomasik Z
    AIDS; 1989 Sep; 3(9):583-9. PubMed ID: 2506903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activities of 20 human immunodeficiency virus type 1 (HIV-1)-specific human monoclonal antibodies.
    Forthal DN; Landucci G; Gorny MK; Zolla-Pazner S; Robinson WE
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1095-9. PubMed ID: 8554906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and human complement: mechanisms of interaction and biological implication.
    Dierich MP; Ebenbichler CF; Marschang P; Füst G; Thielens NM; Arlaud GJ
    Immunol Today; 1993 Sep; 14(9):435-40. PubMed ID: 8216721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV pathogenesis: 25 years of progress and persistent challenges.
    Levy JA
    AIDS; 2009 Jan; 23(2):147-60. PubMed ID: 19098484
    [No Abstract]   [Full Text] [Related]  

  • 11. Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development.
    Neurath AR; Strick N; Taylor P; Rubinstein P; Stevens CE
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1183-92. PubMed ID: 1701315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins.
    Kozlowski PA; Jackson S
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1773-80. PubMed ID: 1457191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of specific IgG antibody production in vivo in infants with congenital HIV, parvovirus B19 or Toxoplasma gondii infection.
    Gerritsen EJ; Dijkstra NH; Van Elsacker-Niele AM; Salimans MM; Goudsmit J; Boer K; Van Knapen F; Stegagno M; Cohen BJ; Rotmans JP
    Immunodeficiency; 1993; 4(1-4):145-8. PubMed ID: 8167690
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro production of HIV-1 specific antibodies from "at risk" seronegative subjects.
    Quarto M; Fiore JR; Chironna M; Fontana A; Germinario C; Troiano T; Fico C; Congedo P; Grottola A; Monno L
    Microbiologica; 1992 Jan; 15(1):29-33. PubMed ID: 1556957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent lack of detectable HIV-1 antibody in a person with HIV infection--Utah, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(9):181-5. PubMed ID: 8604214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of complement-mediated lysis of HIV-1 by a combination of HIV-specific and HLA allotype-specific antibodies.
    Hildgartner A; Wilflingseder D; Gassner C; Dierich MP; Stoiber H; Bánki Z
    Immunol Lett; 2009 Sep; 126(1-2):85-90. PubMed ID: 19698750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
    Hirbod T; Broliden K
    J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Median incubation time for human immunodeficiency virus (HIV).
    Winkelstein W; Royce RA; Sheppard HW
    Ann Intern Med; 1990 May; 112(10):797-8. PubMed ID: 2331124
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Dis Markers; 1990; 8(4):226-7. PubMed ID: 1708319
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential transmission of HIV-1 and HIV-2.
    Christiansen CB; Albert J; Machuca R; Nielsen C
    Lancet; 1997 Aug; 350(9077):562. PubMed ID: 9284781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.